Mirae Asset Global Investments’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
|
|||||
|
2025
Q1 | $104K | Sell |
|
|||||
|
2024
Q4 | $114K | Sell |
|
|||||
|
2024
Q3 | $146K | Buy |
|
|||||
|
2024
Q2 | $140K | Sell |
|
|||||
|
2024
Q1 | $7.45M | Buy |
|
|||||
|
2023
Q4 | $5.6M | Sell |
|
|||||
|
2023
Q3 | $8.39M | Buy |
|
|||||
|
2023
Q2 | $9.41M | Sell |
|
|||||
|
2023
Q1 | $7.74M | Buy |
|
|||||
|
2022
Q4 | $6.65M | Sell |
|
|||||
|
2022
Q3 | $11M | Buy |
|
|||||
|
2022
Q2 | $8.99M | Buy |
|
|||||
|
2022
Q1 | $6.62M | Sell |
|
|||||
|
2021
Q4 | $9.43M | Buy |
|
|||||
|
2021
Q3 | $9.92M | Buy |
|
|||||
|
2021
Q2 | $11.6M | Buy |
|
|||||
|
2021
Q1 | $8.71M | Buy |
|
|||||
|
2020
Q4 | $6.04M | Buy |
|
|||||
|
2020
Q3 | $3.27M | Buy |
|
|||||
|
2020
Q2 | $1.95M | Buy |
|
|||||
|
2020
Q1 | $520K | Buy |
|
|||||
|
2019
Q4 | $667K | Buy |
|
|||||
|
2019
Q3 | $380K | Buy |
|